The DOI matches its Crossref record; 243 of the 243 references it cites were found in a registry or an index.
MYC Oncogene Contributions to Release of Cell Cycle Brakes
Open accessAbstract
Promotion of the cell cycle is a major oncogenic mechanism of the oncogene c-MYC (MYC). MYC promotes the cell cycle by not only activating or inducing cyclins and CDKs but also through the downregulation or the impairment of the activity of a set of proteins that act as cell-cycle brakes. This review is focused on the role of MYC as a cell-cycle brake releaser i.e., how MYC stimulates the cell cycle mainly through the functional inactivation of cell cycle inhibitors. MYC antagonizes the activities and/or the expression levels of p15, ARF, p21, and p27. The mechanism involved differs for each protein. p15 (encoded by CDKN2B) and p21 (CDKN1A) are repressed by MYC at the transcriptional level. In contrast, MYC activates ARF, which contributes to the apoptosis induced by high MYC levels. At least in some cells types, MYC inhibits the transcription of the p27 gene (CDKN1B) but also enhances p27’s degradation through the upregulation of components of ubiquitin ligases complexes. The effect of MYC on cell-cycle brakes also opens the possibility of antitumoral therapies based on synthetic lethal interactions involving MYC and CDKs, for which a series of inhibitors are being developed and tested in clinical trials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–243 of 243
Chandramohan, V., Jeay, S., Pianetti, S., & Sonenshein, G. E. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.9.5522 · Cited by 83
Ras and Myc can drive oncogenic cell proliferation through individual D-cyclins
Yu, Q., Ciemerych, M. A., & Siciński, P. (2005) · Oncogene · doi:10.1038/sj.onc.1208853 · Cited by 80
Chandramohan, V., Mineva, N. D., Burke, B., Jeay, S., Wu, M., Shen, J., Yang, W. E., Hann, S., & Sonenshein, G. E. (2008) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21765 · Cited by 80
The Ever Expanding Role for c-Myc in Promoting Genomic Instability
Prochownik, E. V., & Li, Y. (2007) · Cell Cycle · doi:10.4161/cc.6.9.4161 · Cited by 77
Ras induces p21Cip1/Waf1 cyclin kinase inhibitor transcriptionally through Sp1-binding sites
Kivinen, L., Tsubari, M., Haapajärvi, T., Datto, M., Wang, X.-F., & Laiho, M. (1999) · Oncogene · doi:10.1038/sj.onc.1203000 · Cited by 76
Kazanjian, A. A., WALLIS, D. E., Au, N. H. C., Nigam, R., Venken, K. J. T., Cagle, P. T., Dickey, B. F., Bellen, H. J., Gilks, C. B., & Grimes, H. L. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0633 · Cited by 73
Synthetic Lethal Screens as a Means to Understand and Treat MYC-Driven Cancers
Cermelli, S., Jang, I. S., Bernard, B. M., & Grandori, C. (2014) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a014209 · Cited by 73
Role of flanking E box motifs in human immunodeficiency virus type 1 TATA element function
Ou, S.-H. I., García-Martínez, L. F., Paulssen, E. J., & Gaynor, R. B. (1994) · Journal of Virology · doi:10.1128/jvi.68.11.7188-7199.1994 · Cited by 71
Inhibition of cell differentiation: A critical mechanism for MYC-mediated carcinogenesis?
León, J., Ferrándiz, N., Acosta, J. C., & Delgado, M. D. (2009) · Cell Cycle · doi:10.4161/cc.8.8.8126 · Cited by 69
Self-citationA link between c-Myc-mediated transcriptional repression and neoplastic transformation.
Lee, L. A., Dolde, C. E., Barrett, J., Wu, C. S., & Dang, C. V. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118595 · Cited by 67
Giglio, S., Cirombella, R., Amodeo, R., Portaro, L., Lavra, L., & Vecchione, A. M. (2013) · Journal of Cellular Physiology · doi:10.1002/jcp.24368 · Cited by 66
miR-24 regulates CDKN1B/p27 expression in prostate cancer
Lynch, S. M., McKenna, M. M., Walsh, C. P., & McKenna, D. J. (2016) · The Prostate · doi:10.1002/pros.23156 · Cited by 65
Albajar, M., Gómez-Casares, M. T., Llorca, J., Mauleon, I., Vaqué, J. P., Acosta, J. C., Bermúdez, A., Donato, N., Delgado, M. D., & León, J. (2011) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-10-0356 · Cited by 62
Self-citationRegulation of MYC Expression and Differential JQ1 Sensitivity in Cancer Cells
Fowler, T., Ghatak, P., Price, D. H., Conaway, R., Conaway, J. W., Chiang, C., Bradner, J. E., Shilatifard, A., & Roy, A. L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087003 · Cited by 61
c-Myc antagonizes the effect of p53 on apoptosis and p21WAF1 transactivation in K562 leukemia cells
Ceballos, E., Delgado, M. D., Gutierrez, P., Richard, C., Müller, D., Eilers, M., Ehinger, M., Gullberg, U., & León, J. (2000) · Oncogene · doi:10.1038/sj.onc.1203541 · Cited by 61
Self-citationH-, K- and N-Ras inhibit myeloid leukemia cell proliferation by a p21WAF1-dependent mechanism
Delgado, M. D., Vaque, J. P., Arozarena, I., Lopez-Ilasaca, M. A., Martínez, C., Crespo, P., & León, J. (2000) · Oncogene · doi:10.1038/sj.onc.1203384 · Cited by 60
Self-citationSkórski, T., Nieborowska-Skorska, M., Wlodarski, P. K., Zon, G., Iozzo, R. V., & Calabretta, B. (1996) · Blood · doi:10.1182/blood.v88.3.1005.1005 · Cited by 60
Differential Effects on ARF Stability by Normal versus Oncogenic Levels of c-Myc Expression
Chen, D., Kon, N., Zhong, J., Zhang, P., Yu, L., & Gu, W. J. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.05.006 · Cited by 59
Myc-Induced MicroRNAs Integrate Myc-Mediated Cell Proliferation and Cell Fate
Kim, J. W., Mori, S., & Nevins, J. R. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0659 · Cited by 57
Schneider, A., Peukert, K., Eilers, M., & Hänel, F. (1997) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-60801-8_14 · Cited by 57
MYC-induced metabolic stress and tumorigenesis
Wolpaw, A. J., & Dang, C. V. (2018) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2018.05.003 · Cited by 57
Suppression of p21 by c-Myc through members of miR-17 family at the post-transcriptional level
Xu (2010) · International Journal of Oncology · doi:10.3892/ijo_00000783 · Cited by 54
Vaque, J. P., Navascues, J., Shiio, Y., Laiho, M., Ajenjo, N., Mauleón, I., Matallanas, D., Crespo, P., & León, J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m409503200 · Cited by 50
Self-citationRole of p27Kip1 as a transcriptional regulator
Bachs, O., Gallastegui, E., Orlando, S., Bigas, A., Morante‐Redolat, J. M., Serratosa, J., Fariñas, I., Aligué, R., & Pujol, M. J. (2018) · Oncotarget · doi:10.18632/oncotarget.25447 · Cited by 50
E2F7 regulates transcription and maturation of multiple microRNAs to restrain cell proliferation
Mitxelena, J., Apraiz, A., Vallejo-Rodríguez, J., Malumbres, M., & Zubiaga, A. M. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw146 · Cited by 49
Domain-specific c-Myc ubiquitylation controls c-Myc transcriptional and apoptotic activity
Zhang, Q., Spears, E., Boone, D. N., Li, Z., Gregory, M. A., & Hann, S. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1208334110 · Cited by 46
Wu, M., Bellas, R. E., Shen, J., Yang, W. E., & Sonenshein, G. E. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.12.6530 · Cited by 46
Kinetic profiling of the c-Myc transcriptome and bioinformatic analysis of repressed gene promoters
Yap, C.-S., Peterson, A. L., Castellani, G., Sedivy, J. M., & Neretti, N. (2011) · Cell Cycle · doi:10.4161/cc.10.13.16249 · Cited by 45
Myc lacks E2F1's ability to suppress skin carcinogenesis
Rounbehler, R. J., Schneider‐Broussard, R., Conti, C. J., & Johnson, D. G. (2001) · Oncogene · doi:10.1038/sj.onc.1204691 · Cited by 45
Expression of cyclin D1 mRNA is not upregulated by Myc in rat fibroblasts.
Solomon, D. L., Philipp, A., Land, H., & Eilers, M. (1995) · PubMed · Cited by 41
The SCF-type E3 Ubiquitin Ligases as Cancer Targets
Kitagawa, K., & Kitagawa, M. (2016) · Current Cancer Drug Targets · doi:10.2174/1568009616666151112122231 · Cited by 41
Antagonism of Myc functions by Arf
Cleveland, J. L., & Sherr, C. J. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.09.020 · Cited by 40
Noncatalytic Requirement for Cyclin A-cdk2 in p27 Turnover
Zhu, X., Nguyen, H., Halicka, H. D., Traganos, F., & Koff, A. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.13.6058-6066.2004 · Cited by 38
Sin3b Interacts with Myc and Decreases Myc Levels
García‐Sanz, P., Quintanilla, A., Lafita‐Navarro, M. C., Moreno‐Bueno, G., García-Gutiérrez, L., Tabor, V., Varela, I., Shiio, Y., Larsson, L.-G., Portillo, F., et al. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.538744 · Cited by 35
Self-citationCDK1: beyond cell cycle regulation
Liao, H., Ji, F., & Ying, S. (2017) · Aging · doi:10.18632/aging.101348 · Cited by 34
The ARF Tumor Suppressor: Keeping Myc on a Leash
Gregory, M. A., Qi, Y., & Hann, S. R. (2004) · Cell Cycle · doi:10.4161/cc.4.2.1491 · Cited by 33
c-Myc initiates illegitimate replication of the ribonucleotide reductase R2 gene
Kuschak, T. I., Kuschak, B., Taylor, C., Wright, J., Wiener, F., & Mai, S. (2002) · Oncogene · doi:10.1038/sj.onc.1205145 · Cited by 33
McMahon, S. B. (2010) · Genes & Cancer · doi:10.1177/1947601910379011 · Cited by 30
A role of Miz-1 in Gfi-1-mediated transcriptional repression of CDKN1A
Liu, Q., Basu, S., Qiu, Y., Tang, F., & Dong, F. (2010) · Oncogene · doi:10.1038/onc.2010.48 · Cited by 28
p14ARF directly interacts with Myc through the Myc BoxII domain
Amente, S., Gargano, B., Varrone, F., Ruggiero, L., Dominguez-Sola, D., Lania, L., & Majello, B. (2006) · Cancer Biology & Therapy · doi:10.4161/cbt.5.3.2389 · Cited by 21
Ferrándiz, N., Martín-Pérez, J., Blanco, R. E., Dönertas, D., Weber, A., Eilers, M., Dotto, G. P., Delgado, M. D., & León, J. (2009) · DNA repair · doi:10.1016/j.dnarep.2008.12.001 · Cited by 20
Self-citationE2F7 regulates transcription and maturation of multiple microRNAs to restrain cell proliferation
Vallejo-Rodríguez, J., Mitxelena, J., Apraiz, A., Malumbres, M., & Zubiaga, A. M. (2016) · European Journal of Cancer · doi:10.1016/s0959-8049(16)61601-5 · Cited by 5
(1995) · PubMed
Cited by
ERK signalling: A master regulator of cell behaviour, life and fate
Lavoie, H., Gagnon, J., & Therrien, M. (2020) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-0255-7 · Cited by 1,185
The MYC oncogene — the grand orchestrator of cancer growth and immune evasion
Dhanasekaran, R., Deutzmann, A., Mahauad-Fernandez, W. D., Hansen, A. S., Gouw, A. M., & Felsher, D. W. (2022) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-021-00549-2 · Cited by 986
Induced pluripotent stem cells (iPSCs): molecular mechanisms of induction and applications
Cerneckis, J., Cai, H., & Shi, Y. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01809-0 · Cited by 452
Hammond, C. A., Wu, S. W., Wang, F., MacAldaz, M. E., & Eaves, C. J. (2023) · Blood · doi:10.1182/blood.2022017174 · Cited by 40
Metadata
- Authors
- García-Gutiérrez, L., Delgado, M. D., & León, J.
- Venue
- Genes
- Publisher
- MDPI AG
- Published
- 2019-03-22
- Volume
- 10
- Issue
- 3
- Pages
- 244
- ISSN
- 2073-4425 (ISSN-L)
- OpenAlex
- W2941930792
- Cited by
- 255
- References
- 243
- FWCI
- 8.80
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.